1. A Large Grade 5 Mobile Aortic Arch Atheromatous Plaque: Cause of Cerebrovascular Accident
   Chikezie Alvarez et al, 2018, Case Reports in Medicine CrossRef
2. PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets
   Yi Zheng et al, 2024, Journal of Advanced Research CrossRef
3. Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension
   Taijyu Satoh et al, 2017, Circulation Research CrossRef
4. Cerebral small vessel disease: Pathological mechanisms and potential therapeutic targets
   Yue Gao et al, 2022, Frontiers in Aging Neuroscience CrossRef
5. Sivelestat sodium hydrate improves post-traumatic knee osteoarthritis through nuclear factor-κB in a rat model
   Xiaofeng Yu et al, 2017, Experimental and Therapeutic Medicine CrossRef
6. First clinical and myopathological description of a myofibrillar myopathy with congenital onset and homozygous mutation in FLNC
   Heike Kölbel et al, 2020, Human Mutation CrossRef
7. Cardiovascular comorbidities, inflammation, and cerebral small vessel disease
   Lowri E Evans et al, 2021, Cardiovascular Research CrossRef
8. Effects of conditioned media from human umbilical cord blood-derived mesenchymal stem cells in the skin immune response
   Yoon-Jin Kim et al, 2020, Biomedicine & Pharmacotherapy CrossRef
9. The relevance of serum macrophage migratory inhibitory factor and cognitive dysfunction in patients with cerebral small vascular disease
   Jianhua Zhao et al, 2023, Frontiers in Aging Neuroscience CrossRef
10. Superoxide-Mediated Upregulation of MMP9 Participates in BMPR2 Destabilization and Pulmonary Hypertension Development
    Norah Alruwaili et al, 2023, Antioxidants CrossRef
11. Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study
    Alex R. Jenkins et al, 2020, COPD: Journal of Chronic Obstructive Pulmonary Disease CrossRef